MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1

被引:88
作者
Ruprecht, Claudia R. [1 ]
Krarup, Anders [1 ]
Reynell, Lucy [1 ,2 ]
Mann, Axel M. [1 ,2 ]
Brandenberg, Oliver F. [1 ,2 ]
Berlinger, Livia [1 ]
Abela, Irene A. [1 ,2 ,3 ]
Regoes, Roland R. [5 ]
Guenthard, Huldrych F. [4 ]
Rusert, Peter [1 ]
Trkola, Alexandra [1 ]
机构
[1] Univ Zurich, Inst Med Virol, CH-8006 Zurich, Switzerland
[2] Univ Zurich, PhD Program Microbiol & Immunol, CH-8006 Zurich, Switzerland
[3] Univ Zurich, MD PhD Program, CH-8006 Zurich, Switzerland
[4] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, CH-8006 Zurich, Switzerland
[5] Swiss Fed Inst Technol, Inst Integrat Biol, CH-8092 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; SOLUBLE CD4; ENVELOPE GLYCOPROTEIN; NONNEUTRALIZING ANTIBODIES; HUMORAL IMMUNITY; LYMPHOID-TISSUES; STRUCTURAL BASIS; EARLY INFECTION;
D O I
10.1084/jem.20101907
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interference with virus entry is known to be the principle mechanism of HIV neutralization by antibodies, including 2F5 and 4E10, which bind to the membrane-proximal external region (MPER) of the gp41 envelope protein. However, to date, the precise molecular events underlying neutralization by MPER-specific antibodies remain incompletely understood. In this study, we investigated the capacity of these antibodies to irrevocably sterilize HIV virions. Long-term effects of antibodies on virions can differ, rendering neutralization either reversible or irreversible. MPER-specific antibodies irreversibly neutralize virions, and this capacity is associated with induction of gp120 shedding. Both processes have similar thermodynamic properties and slow kinetics requiring several hours. Antibodies directed to the CD4 binding site, V3 loop, and the MPER can induce gp120 shedding, and shedding activity is detected with high frequency in plasma from patients infected with divergent genetic HIV-1 subtypes. Importantly, as we show in this study, induction of gp120 shedding is closely associated with MPER antibody inhibition, constituting either a primary event leading to virion neutralization or representing an immediate consequence thereof, and thus needs to be factored into the mechanistic processes underlying their activity.
引用
收藏
页码:439 / 454
页数:16
相关论文
共 71 条
  • [21] Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State
    Haim, Hillel
    Si, Zhihai
    Madani, Navid
    Wang, Liping
    Courter, Joel R.
    Princiotto, Amy
    Kassa, Aemro
    DeGrace, Marciella
    McGee-Estrada, Kathleen
    Mefford, Megan
    Gabuzda, Dana
    Smith, Amos B., III
    Sodroski, Joseph
    [J]. PLOS PATHOGENS, 2009, 5 (04)
  • [22] Fc receptor but not complement binding is important in antibody protection against HIV
    Hessell, Ann J.
    Hangartner, Lars
    Hunter, Meredith
    Havenith, Carin E. G.
    Beurskens, Frank J.
    Bakker, Joost M.
    Lanigan, Caroline M. S.
    Landucci, Gary
    Forthal, Donald N.
    Parren, Paul W. H. I.
    Marx, Preston A.
    Burton, Dennis R.
    [J]. NATURE, 2007, 449 (7158) : 101 - U75
  • [23] Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
    Hessell, Ann J.
    Rakasz, Eva G.
    Tehrani, David M.
    Huber, Michael
    Weisgrau, Kimberly L.
    Landucci, Gary
    Forthal, Donald N.
    Koff, Wayne C.
    Poignard, Pascal
    Watkins, David I.
    Burton, Dennis R.
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (03) : 1302 - 1313
  • [24] Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
    Hessell, Ann J.
    Poignard, Pascal
    Hunter, Meredith
    Hangartner, Lars
    Tehrani, David M.
    Bleeker, Wim K.
    Parren, Paul W. H. I.
    Marx, Preston A.
    Burton, Dennis R.
    [J]. NATURE MEDICINE, 2009, 15 (08) : 951 - U155
  • [25] Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
    Hessell, Ann J.
    Rakasz, Eva G.
    Poignard, Pascal
    Hangartner, Lars
    Landucci, Gary
    Forthal, Donald N.
    Koff, Wayne C.
    Watkins, David I.
    Burton, Dennis R.
    [J]. PLOS PATHOGENS, 2009, 5 (05)
  • [26] Role for CD21 in the establishment of an extracellular HIV reservoir in lymphoid tissues
    Ho, Jason
    Moir, Susan
    Kulik, Liudmila
    Malaspina, Angela
    Donoghue, Eileen T.
    Miller, Natalie J.
    Wang, Wei
    Chun, Tae-Wook
    Fauci, Anthony S.
    Holers, V. Michael
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (11) : 6968 - 6974
  • [27] Humoral immunity to HIV-1: neutralization and beyond
    Huber, M.
    Trkola, A.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2007, 262 (01) : 5 - 25
  • [28] Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection
    Huber, Michael
    Fischer, Marek
    Misselwitz, Benjamin
    Manrique, Amapola
    Kuster, Herbert
    Niederoest, Barbara
    Weber, Rainer
    von Wyl, Viktor
    Guenthard, Huldrych F.
    Trkola, Alexandra
    [J]. PLOS MEDICINE, 2006, 3 (11) : 2078 - 2093
  • [29] Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
    Kilby, JM
    Hopkins, S
    Venetta, TM
    DiMassimo, B
    Cloud, GA
    Lee, JY
    Alldredge, L
    Hunter, E
    Lambert, D
    Bolognesi, D
    Mathews, T
    Johnson, MR
    Nowak, MA
    Shaw, GM
    Saag, MS
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1302 - 1307
  • [30] Molecular characterization of five neutralizing anti-HIV type 1 antibodies:: Identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5
    Kunert, R
    Rüker, F
    Katinger, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (13) : 1115 - 1128